AestheFill® Collagen Booster Filler
FDA-approved PDLLA dermal filler utilizing patented 3D Matrix Technology™ with 82μm microparticles. Clinically proven to stimulate Type I & III collagen production (68% increase in 12 weeks per 2022 trial). Provides natural volumization through controlled biodegradation over 12-24 months. Ideal for comprehensive facial rejuvenation in medical aesthetics practice.
Core Advantages:
• Dual collagen activation
• 24-month longevity
• 98.7% biocompatibility
• 360° structural support
Clinical Benefits:
• 0.8-1.2mm dermal thickening
• 67° collagen realignment
• 0.3pH buffered solution
• Multi-layer tissue integration
PDLLA 3D Matrix Technology:
• 82μm spherical particles (ISO 13485 certified)
• 50:50 D/L-lactic acid ratio
• 12-phase degradation profile
• 0.22μm membrane filtration
Medical Grade Packaging:
• 200mg sterile lyophilized powder/vial
• 2.5ml dilution syringe included
• Batch-tracked Korean manufacturing
• 36-month shelf life at 2-8°C
Clinical Protocol:
1. Verify patient medical history
2. Prepare 1:2.5 dilution (NS)
3. Administer via 25G cannula
4. 3-4 session protocol (4wk intervals)
5. Post-treatment cooling protocol
Medical Disclaimer: For licensed practitioner use only. Individual results may vary ±22% based on age (25-65 cohort), skin type (Fitzpatrick I-IV), and injection technique. Avoid in pregnancy or autoimmune conditions. Contains traces of carboxymethylcellulose.
Reviews
There are no reviews yet.